Answers are grounded in this paper and cite their sources.
Currently, the main approach to treatment of malignant tumors of the renal pelvis is radical nephroureterectomy. In some patient categories, organ-sparing surgeries are possible if several criteria are met. According to scientific publications, tumor recurrence and progression rates significantly vary in non-radical surgical treatment, and outcomes are contradictory. The article presents a clinical case of organ-sparing treatment of a young patient with progressive urothelial carcinoma.
No takes yet. Share an insight, caveat, or question.
Protoshchak et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: